Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk
In Good Company with Nicolai Tangen
Intro
This chapter examines obesity as a complex disease influenced by genetics, food accessibility, and demographics. It also discusses the economic implications of obesity and the advancements in weight reduction medicines that provide new hope for individuals facing weight management challenges.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
